---
DrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SubClass: "[[Disease-modifying antirheumatic drugs (DMARDs)-Biologics]]"
DrugClassContra: "[[Disease-modifying antirheumatic drugs (DMARDs)#Contraindications]]"
DrugClassAdverse: "[[Disease-modifying antirheumatic drugs (DMARDs)#Adverse Reactions]]"
SecondaryDrugClass: "[[Immune Blockers]]"
SecondarySubClass: "[[Monoclonal antibodies]]"
BrandName: Orencia
Chapter: "29"
KindleLinkChap: "[Chapter 29](kindle://book?action=open&asin=B09FRF11YJ&location=15248)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
SecondaryAdverse: "[[Monoclonal antibodies#Adverse Reactions]]"
SecondaryContra: "[[Monoclonal antibodies#Contraindications]]"
SubCat: Rheumatoid Arthritis
---
```smiles

```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Arthritis— juvenile idiopathic, psoriatic, rheumatoid 
500– 750 mg IV every 4 weeks

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action
- [T-lymphocyte activation antigen CD80](https://go.drugbank.com/drugs/DB01281#BE0000847)
    
    Antagonist
    
- [T-lymphocyte activation antigen CD86](https://go.drugbank.com/drugs/DB01281#BE0000846)
    
    Antagonist

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Headache, nasal congestion, upper [[Respiratory]] infection (URI) symptoms, nausea

### Interactions

`= this.ChemLink+this.file.name`

